{"company": {"org_id": "T000271176", "org_name_cn": "江西同和药业股份有限公司", "org_short_name_cn": "同和药业", "org_name_en": "Jiangxi Synergy Pharmaceutical Co.,Ltd.", "org_short_name_en": "SYNERGY", "main_operation_business": "化学原料药和医药中间体的研发、生产和销售。", "operating_scope": "　　许可项目：药品生产，药品进出口，兽药生产，危险化学品生产（依法须经批准的项目，经相关部门批准后方可开展经营活动，具体经营项目以相关部门批准文件或许可证件为准）一般项目：化工产品生产（不含许可类化工产品），基础化学原料制造（不含危险化学品等许可类化学品的制造）（除依法须经批准的项目外，凭营业执照依法自主开展经营活动）", "district_encode": "360921", "org_cn_introduction": "江西同和药业股份有限公司的主营业务是化学原料药和医药中间体的研发、生产和销售。公司的主要产品是加巴喷丁原料药、瑞巴派特原料药、醋氯芬酸原料药、塞来昔布原料药、坎地沙坦酯原料药、阿齐沙坦原料药、沙坦类中间体、达比加群酯原料药、替格瑞洛原料药、阿哌沙班原料药、利伐沙班原料药、维格列汀原料药、恩格列净原料药、盐酸文拉法辛原料药、阿戈美拉汀原料药、非布司他原料药、米拉贝隆原料药。公司获批设立了“江西省特色原料药工程中心”、“江西省企业技术中心”、“博士后科研实践基地”、“博士后科研工作站”、“江西省新药研发产教融合创新中心”等科研中心，2023年继续被认定为“高新技术企业”。", "legal_representative": "庞正伟", "general_manager": "庞正伟", "secretary": "周志承", "established_date": 1082390400000, "reg_asset": 419951495.0, "staff_num": 1418, "telephone": "86-795-4605333-8018;86-795-4605333-8012", "postcode": "330700", "fax": "86-795-4605772", "email": "sa@jxsynergy.com;dm@jxsynergy.com;zhangbo@jxsynergy.com", "org_website": "www.jxsynergy.com", "reg_address_cn": "江西省宜春市奉新县江西奉新高新技术产业园区", "reg_address_en": null, "office_address_cn": "江西省宜春市奉新县江西奉新高新技术产业园区", "office_address_en": null, "currency_encode": "019001", "currency": "CNY", "listed_date": 1490889600000, "provincial_name": "江西省", "actual_controller": "庞正伟 (14.71%)，梁忠诚 (14.09%)", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "庞正伟", "executives_nums": 16, "actual_issue_vol": 20000000.0, "issue_price": 14.47, "actual_rc_net_amt": 263030000.0, "pe_after_issuing": 22.98, "online_success_rate_of_issue": 0.01412996, "affiliate_industry": {"ind_code": "BK0040", "ind_name": "化学制药"}}}